David

982 posts

David

David

@BarnyardBull72

Trader 📈 bio-hacker 🧬 and weight lifter 💪🏼 Peptides are the future. Disclosure: Opinions only, not investment advice. DYOR. High risk, High reward stocks.

🇺🇸 Katılım Kasım 2024
252 Takip Edilen147 Takipçiler
David
David@BarnyardBull72·
@investseekers And once again. Lexaria Bioscience is in an exclusive MTA with Novo or Lily. Lexaria’s dehydraTECH reduces Adverse events drastically. Whoever solves tolerability, wins. Period. $LEXX
English
0
0
0
2
Investseekers
Investseekers@investseekers·
$NVO is pushing back hard as the oral GLP-1 battle with $LLY intensifies. In a new cross-trial comparison, Novo says oral Wegovy delivered greater average weight loss than Foundayo and showed materially better tolerability. The most striking datapoint: Lilly’s pill was associated with ~14x higher odds of treatment discontinuation due to side effects in the indirect analysis. Novo also said 84% of surveyed patients preferred a treatment profile similar to oral semaglutide. This reinforces the core debate in the pill market: • Novo → stronger weight loss and tolerability • Lilly → greater convenience with no fasting restrictions With weekly script trends now under close watch, this efficacy vs convenience narrative may drive sentiment for both stocks over the coming months. Link to article: cnbc.com/2026/04/02/nov… #stocks #Investing
English
4
2
19
1.5K
David
David@BarnyardBull72·
@FirstSquawk $LEXX solves this issue 🤝 $NVO
English
0
1
0
324
First Squawk
First Squawk@FirstSquawk·
NOVO NORDISK'S ORFORGLIPRON 36MG TREATMENT HAS 14 TIMES GREATER CHANCES OF BEING DISCONTINUED DUE TO GASTROINTESTINAL SIDE EFFECTS COMPARED TO WEGOVY PILL 25MG.
English
25
5
102
38.2K
David
David@BarnyardBull72·
$LEXX add to the Bull case and most importantly 🚨 🐂 Lexaria is currently in an exclusive and extended MTA with a global Pharma company speculated to be $NVO or $LLY. Simultaneously they are having discussions with several other Pharma companies regarding the dehydraTECH platform. 🔥🔥🔥😮‍💨☝🏻🤝
William Paulson@Billerrr1

$LEXX — Bullish 🚀 🏷️ $0.808 Lexaria to Begin New Human Clinical Study in GLP-1 Bull Case: + Lexaria is initiating a new human clinical study (Pilot Study #7) in the highly sought-after GLP-1 market, a sector currently experiencing immense investor interest and growth (e.g., Wegovy, Rybelsus). + The study introduces significant new DehydraTECH enhancements, including an oral tablet formulation designed to mimic properties of Novo Nordisk's successful Rybelsus/Wegovy tablets and the first multi-dose, multi-week evaluation of SNAC-formulated test articles in humans, aiming for superior PK performance. + The study is fully funded from existing corporate resources, mitigating immediate dilution concerns, and is explicitly aimed at generating interest from pharmaceutical partners, which would be a major catalyst for the company. Bear Case: − The study is in its very early stages, with ethics approval pending and patient recruitment yet to begin, meaning actual clinical results or data are many weeks to months away. − Clinical trials carry inherent risks, and there is no guarantee that the study will achieve its desired outcomes, match or exceed the performance of commercial products, or lead to successful partnerships. #pennystocks #daytrading Not financial advice. DYOR.

English
0
2
4
1.3K
David retweetledi
Top Stock Alerts
Top Stock Alerts@TopStockAlerts1·
$LEXX too strong to ignore
English
0
1
1
613
David retweetledi
Top Stock Alerts
Top Stock Alerts@TopStockAlerts1·
$LEXX solid trades today ✅
English
0
1
1
788
David retweetledi
David
David@BarnyardBull72·
$LEXX 👀. ⏰ 💣.
1
1
2
191
David retweetledi
Top Stock Alerts
Top Stock Alerts@TopStockAlerts1·
$LEXX waking up
English
0
3
1
688
David retweetledi
Bio&c 🏦🧬
Bio&c 🏦🧬@biotech_cash·
$LEXX MTA under review 7000pages and today Contracts signed for Human Pilot Study #7 (GLP-1-H26-7) ….. @BarnyardBull72 👀📡🚀
English
0
3
4
288
David retweetledi
Volodymyr Zelenskyy / Володимир Зеленський
When I travel outside of Ukraine, I get daily intelligence updates online. This morning, I was briefed that U.S. military facilities in the Middle East and the Gulf region were photographed by Russian satellites in the interests of Iran. On March 24th, they imaged the U.S.–UK joint military facility on Diego Garcia located in the Chagos Archipelago in the Indian Ocean. They also captured pictures of Kuwait International Airport and parts of the infrastructure of the Greater Burgan oil field. On March 25th, they took pictures of the Prince Sultan Air Base in Saudi Arabia. The Shaybah oil and gas field in Saudi Arabia, İncirlik Air Base in Türkiye, and Al Udeid Air Base in Qatar were all imaged on March 26th. There are no Ukrainian facilities on this list. But who is helping whom when sanctions are lifted from an aggressor that earns daily revenue and provides intelligence for strikes against American, Middle Eastern, UK, and U.S.–UK bases and so on? When surveillance is carried out over facilities in Ukraine, we always understand that they must be protected, since plans are in motion to destroy them – energy and water infrastructure, military facilities, and so on. Everyone knows that repeated reconnaissance indicates preparations for strikes. How can sanctions be eased if this is what the Russians are doing? There must be pressure on the aggressor. And lifting sanctions is certainly not pressure. It looks strange. Sanctions are being lifted, while the aggressor is providing intelligence to strike facilities, including those of the countries that are discussing or have already lifted sanctions. From my conversation with journalists (3/3).
English
1.5K
10.3K
41.8K
3.4M
David retweetledi
ALLATRA IPM
ALLATRA IPM@allatra_ipm·
Microplastics are already inside us and they are affecting our health. Professor Ragusa explains where the real problem lies and why it's not just about plastic. Are you ready to find out what each of us needs to do to solve this problem? For more details, follow the link.
English
849
11.7K
66.4K
76.7M
David
David@BarnyardBull72·
@TopStockAlerts1 @AlaskaAir take note and add seat-back screens and lie flat seats on domestic narrow body aircraft ✈️ ☝🏻💡
English
0
0
0
29
Top Stock Alerts
Top Stock Alerts@TopStockAlerts1·
American Airlines is in talks with SpaceX’s Starlink and Amazon to revamp in-flight internet and entertainment, according to a person familiar with the matter. The carrier is also considering adding seatback screens again to its narrow-body fleet. American is under pressure from U.S. profit leaders Delta Air Lines and United Airlines, which have spent years investing in their on-board products. $AAL
English
1
0
0
964